This federal Project Grant award of $431,750 from the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs will fund a multi-method investigation of premium cigar use and marketing. The study aims to: 1) understand consumer experiences and perceptions of premium cigars through focus groups; 2) document and characterize premium cigar marketing through a longitudinal content analysis; and 3) assess the effect of premium cigar advertisement features...
The National Cancer Institute (NCI) awarded a $371,822 Project Grant under CFDA 93.393 - Cancer Cause and Prevention Research to Rutgers, The State University of New Jersey on February 1, 2025. The grant will fund a series of complementary studies to characterize changes in cigar pack size over time and assess its impact on sales, consumption, and patterns of use using secondary data. Additionally, the project will examine how pack size, price, and flavor affect product preferences among diverse...
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...
This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the continuum of risk for tobacco products. The project aims to assess the effects of FDA tobacco product risk continuum messaging on adult combustible tobacco users and youth/young adult tobacco users or...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 (Trans-NIH Research Support) is supporting a $675,599 study titled "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale". The primary awardee is Rutgers, The State University of New Jersey, who will collaborate with Columbia University on the project. The study aims to: 1) characterize the implementation and reach of...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research program provides $3,230,000 to The Regents of the University of California, San Francisco (UCSF) to investigate the cardiovascular effects of dual use of tobacco and nicotine delivery products like cigarettes and e-cigarettes. The project aims to (1) understand the cardiovascular health effects of dual use...
This Project Grant award from the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $1,197,896 to the University of Oklahoma Health Sciences Center to conduct a longitudinal study examining the impact of electronic nicotine delivery system (ENDS) product characteristics on use behaviors and abuse liability among young adults. The study will utilize a combination of traditional survey methods and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA Program 93.077 - Family Smoking Prevention and Tobacco Control Act Regulatory Research provides $188,913 to Virginia Commonwealth University (VCU) from August 1, 2024 to July 31, 2029. The purpose of the grant is to assess perceptions of the continuum of risk among socioeconomically disadvantaged adult smokers, design and test educational messages about the relative risks of...
This $773,359 federal Project Grant award, funded by the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), will support a randomized controlled trial to evaluate the effectiveness of nicotine pouches as a cigarette substitute. The University of Wisconsin-Madison will conduct this 5-year research study to assess how readily smokers will adopt nicotine pouches, how effectively pouches can substitute for...
This Project Grant award from the National Institutes of Health (NIH), under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), will fund research on the prevalence and effects of "natural" descriptors and imagery used in cigar packaging.
The $2,353,743 award to Rutgers, The State University of New Jersey will support a 5-year study to: 1) analyze Nielsen cigar sales data and purchased cigar packs to examine the use of "natural" themed descriptors and imagery on cigar packaging over time; 2) test the effects of "natural" descriptors and imagery on young adults' cigar perceptions, appeal, and use intentions through online experiments; and 3) conduct an in-person eye-tracking study to assess real-world attention to "natural" claims on cigar packs.
The research aims to inform the FDA's regulatory approach to cigar marketing and labeling, as well as priorities around understanding marketing influences, communications, and consumer behavior related to tobacco products.